Hhdpharm High Quality Anti-Cancer Daclatasvir CAS 1009119-65-6

• Customization: Available
• Powder: Yes
• Customized: Non-Customized
• Model NO.: CAS 1009119-65-6
• Certification: Enterprise Standards
• Suitable for: Adult
• State: Powder
• Purity: >98%
• Color: White
• Grade: Pharmaceutical Grade
• Shelf Life: 2 Years
• Model No: Hhd
• Transport Package: Alumininum Foli Bags
• Specification: 10g, 50g, 200g, 1kg, 5kg
• Trademark: hhdpharm
• Origin: China

Product Description

Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection.Hepatitis C is an infectious liver disease caused by infection with Hepatitis C Virus (HCV). 

Product Name	Wholesale price cas 1009119-64-5 Raw Material bulk Daclatasvir powder
Appearance	White powder
Molecular formula	C40h50n8o6
Molecular Weight	738.88
Keywords	Raw Material Daclatasvir ,Raw Material Daclatasvir powder,bulk Daclatasvir powder
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

Daclatasvir was discovered as a first-in-class inhibitor of the non-structural viral protein 5A (NS5A), a phosphoprotein that
plays an important role in hepatitis C replication.

Function of Daclatasvir 

Daclatasvir (Daklinza) has obtained "priority review" status, combined with sorafenib for the treatment of genotype III adult patients with chronic hepatitis C. Daklinza has been the first drug that has been proved of being effective in the treatment of genotype III hepatitis C virus infection without the co-administration with interferon or ribavirin. Interferon and ribavirin are two drugs approved by FDA for the treatment of hepatitis C virus infection. Hepatitis C is a viral disease that can cause inflammation of the liver, resulting in decreased liver function or liver failure. Most patients infected with hepatitis C have no symptoms until liver damage becomes apparent, which may take several years...

Globally, genotype III hepatitis C is the second most common genotype of hepatitis C after genotype 1 hepatitis C and is considered to be one of the most refractory genotype diseases. Daklinza is a pan-genotype NS5A replication complex inhibitor, with efficacy of inhibition of RNA replication and viral assembly, dual antiviral effect..

Packaging & Shipping

Our service

1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week  for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: